These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21763018)

  • 1. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.
    Battistoni A; Rubattu S; Volpe M
    Int J Cardiol; 2012 May; 157(2):160-8. PubMed ID: 21763018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
    Searle J; Danne O; Müller C; Mockel M
    Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular biomarkers in the ICU.
    Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of cardiac biomarkers in dialysis patients.
    Wang AY; Wai-Kei Lam C
    Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.
    van der Zee PM; Cornel JH; Bholasingh R; Fischer JC; van Straalen JP; De Winter RJ
    Am J Med; 2011 Oct; 124(10):961-9. PubMed ID: 21962317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in acute cardiovascular disease.
    Howie-Esquivel J; White M
    J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of natriuretic peptides in dialysis patients.
    Wang AY
    Semin Dial; 2012 May; 25(3):326-33. PubMed ID: 22607214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating biomarkers.
    Badimon L; Romero JC; Cubedo J; Borrell-Pagès M
    Thromb Res; 2012 Oct; 130 Suppl 1():S12-5. PubMed ID: 23026650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical utility of the cardiac markers BNP and NT-proBNP].
    Buchner S; Riegger G; Luchner A
    Acta Med Austriaca; 2004; 31(4):144-51. PubMed ID: 15732251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.
    Marcovina SM; Crea F; Davignon J; Kaski JC; Koenig W; Landmesser U; Pieri PL; Schulz-Menger J; Shaw LJ; Sobesky J
    J Intern Med; 2007 Mar; 261(3):214-34. PubMed ID: 17305644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old and new biomarkers of heart failure.
    Emdin M; Vittorini S; Passino C; Clerico A
    Eur J Heart Fail; 2009 Apr; 11(4):331-5. PubMed ID: 19329823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP.
    Giannitsis E
    Clin Lab; 2005; 51(1-2):63-83. PubMed ID: 15719708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
    Chaykovska L; Tsuprykov O; Hocher B
    Clin Lab; 2011; 57(7-8):455-67. PubMed ID: 21888009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in cardiovascular disease: beyond natriuretic peptides.
    Boswood A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S23-32. PubMed ID: 19395333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natriuretic peptides in clinical practice].
    Urek R; Cubrilo-Turek M
    Acta Med Croatica; 2008 Feb; 62(1):53-6. PubMed ID: 18365500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.